We found that medial VSMCs, but not adventitial fibroblasts, from AAA patients expressed dramatically more CCL19, CCL20, CCL21, CXCL13, and CXCL16 chemokines than cells from control aortas. This evidence concerns the gene CCL19 and triple-A syndrome.